The U.S. Durable Medical Equipment market size was exhibited at USD 59.9 billion in 2022 and is projected to hit around USD 105.26 billion by 2032, growing at a CAGR of 5.8% during the forecast period 2023 to 2032.
Key Pointers:
U.S. Durable Medical Equipment Market Report Scope
Report Coverage |
Details |
Market Size in 2023 |
USD 63.37 Billion |
Market Size by 2032 |
USD 105.26 Billion |
Growth Rate from 2023 to 2032 |
CAGR of 5.8% |
Base year |
2022 |
Forecast period |
2023 to 2032 |
Segments covered |
Product, end-use |
Report coverage |
Revenue forecast, competitive landscape, growth factors, and trends |
Key companies profiled |
Invacare Corp.; Sunrise Medical; Arjo; Medline Industries, Inc.; GF Healthcare Products, Inc.; Carex Health Brands, Inc.; Cardinal Health; Drive DeVilbiss Healthcare; NOVA Medical Products; Kaye Products, Inc. |
The COVID-19 pandemic has affected the supply chain of durable medical equipment (DME). The market is majorly driven by the rising product demand due to the growing geriatric population that is susceptible to various chronic diseases, such as cancer, diabetes, Cardiovascular Diseases (CVDs), neurological disorders, and mobility disorders.
The COVID-19 pandemic has initially disrupted the market due to the lack of accessibility of the products to the customers. The pandemic has affected the operations and financial condition of various market players. The DME suppliers have encountered interruptions in the supply chain, such as significant delays and order cancellations, as a result of public health and economic emergencies related to the COVID-19 pandemic.
The durable medical equipment suppliers are facing numerous challenges in serving patients requiring respiratory support and other DME-related services. Cancer is a leading cause of death globally accounting for 10 million deaths in 2020. As per the National Cancer Institute Report 2018, approximately 1.7 million people in the U.S. were diagnosed with cancer.
It is predicted that there will be a 70.0% rise in the new cases of cancer over the next couple of years (about 1.1 million people). The rising prevalence of neurological diseases, such as Alzheimer’s, Parkinson’s, and Epilepsy, is also expected to fuel the product demand. As per the statistics of the Centers for Disease Control and Prevention, in 2020, 5.8 million Americans were living with Alzheimer’s disease. The rising prevalence of diseases is expected to result in an increase in demand for DME over the forecast period. In addition, an increase in healthcare spending across the country is expected to boost market growth.
The demographic shifts underlie the projected growth in the U.S. healthcare expenditure from USD 3.5 trillion in 2017 to USD 6.2 trillion in 2028 and account for 20% of the GDP. The anticipated growth in the annual spending for Medicare (7.9%) is projected to contribute significantly to the increase in the national health expenditure over the forecast period. Since its inception, Medicare has accounted for an increasing proportion of the total healthcare expenditure. Medicare has covered 18.4% of U.S. Americans in 2020 and in 2021, more than 26 million people enrolled in Medicare Advantage Plan.
Product Insights
The monitoring and therapeutic devices segment held the largest revenue share of over 89.11% in 2022 due to the increasing prevalence of chronic diseases requiring long-term care. In addition, increasing patient preference for at-home medical treatment or remote medical services over an in-patient setting is contributing to the segment growth. In monitoring and therapeutic devices, neuromonitoring techniques are expected to witness growth over the forecast period as they are becoming a part of standard medical practices and are routinely used during many surgical procedures.
The personal mobility devices segment is anticipated to register the fastest growth rate of 6.2% during the forecast period. The growing geriatric population and rising chronic illnesses are likely to create more need and demand for mobility products over the forecast period as these factors generally reduce the ability to move and perform physical tasks to maintain independent functioning. Moreover, aged people are more prone to falls, which can cause fatal or non-fatal injuries.
Some of the prominent players in the U.S. Durable Medical Equipment Market include:
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global U.S. Durable Medical Equipment market.
By Product
By End-use
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Nova one advisor’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
1.9.3. Objective 3
1.9.4. Objective 4
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product
2.3. Competitive Insights
Chapter 3. U.S. Durable Medical Equipment Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of chronic diseases requiring long term care
3.4.1.2. Rapidly growing geriatric population
3.4.1.3. Increasing penetration of home healthcare services and staff
3.4.2. Market restraint analysis
3.4.2.1. High purchasing and maintenance cost
3.4.2.2. Lack of skilled professionals to handle this equipment
3.4.3. Industry challenge
3.4.3.1. Product recall
3.4.3.2. Rising competition
3.4.4. COVID - 19 impact on the industry
3.5. U.S. Durable Medical Equipment Market Analysis Tools
3.5.1. Industry Analysis - Porter’s Five Forces
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.6. DME Coverage
3.6.1. Competitive bidding dynamics and DME
3.6.2. Medicaid and DME
3.6.3. DME coverage pattern (Percentage):
3.6.3.1. U.S. personal mobility devices reimbursement coverage, 2019
3.6.3.2. U.S. bathroom safety devices and medical furniture reimbursement coverage, 2019
3.6.3.3. U.S. monitoring and therapeutic devices reimbursement coverage, 2019
3.4.4. Prescription Submission Analysis
3.4.5. List of DME suppliers in the U.S.
Chapter 4. U.S. Durable Medical Equipment Market: Product Estimates & Trend Analysis (Value and Volume)
4.1. Definitions and Scope
4.1.1. Personal Mobility Devices
4.1.1.1. Wheelchairs
4.1.1.2. Scooters
4.1.1.3. Walker & Rollators
4.1.1.4. Canes & Crutches
4.1.1.5. Door Openers
4.1.1.6. Others
4.1.2. Bathroom Safety Devices & Medical Furniture
4.1.2.1. Commodes & Toilets
4.1.2.2. Mattress & Bedding Devices
4.1.3. Monitoring & Therapeutic Devices
4.1.3.1. Blood Glucose MonitorsBlood Glucose Monitors
4.1.3.2. Continuous Passive Motion (CPM)
4.1.3.3. Infusion Pumps
4.1.3.4. Nebulizers
4.1.3.5. Oxygen Equipment
4.1.3.6. Continuous Positive Airway Pressure (CPAP)
4.1.3.7. Suction Pumps
4.1.3.8. Traction Equipment
4.1.3.9. Others
4.1.3.9.1. Insulin Pumps
4.1.3.9.2. Ostomy Bags & Accessories
4.1.3.9.3. Wound Care Products
4.1.3.9.4. Cardiology Devices
4.1.3.9.5. Vital Signs Monitor
4.1.3.9.6. Respiratory Supplies
4.1.3.9.7. Urinary Supplies
4.1.3.9.8. Diabetic Supplies
4.1.3.9.9. Incontinence Products
4.1.3.9.10. Orthopedic Braces & Support
4.1.3.9.11. Muscle Stimulators
4.1.3.9.12. Others
4.2. Segment Dashboard
4.3. The U.S. Durable Medical Equipment Market Share, 2021 & 2030
4.4. The U.S. Durable Medical Equipment Market by Product Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1. Personal Mobility Devices
4.5.1.1. Wheelchairs
4.5.1.1.1. Electric wheelchairs
4.5.1.1.2. Manual wheelchairs
4.5.1.2. Scooters
4.5.1.3. Walker & Rollators
4.5.1.4. Canes & Crutches
4.5.1.5. Door Openers
4.5.1.6. Others
4.5.2. Bathroom Safety Devices and Medical Furniture
4.5.2.1. Commodes & Toilets
4.5.2.2. Mattress & Bedding Devices
4.5.3. Monitoring and Therapeutic Devices
4.5.3.1. Blood Glucose Monitors
4.5.3.2. Continuous Passive Motion (CPM)
4.5.3.3. Infusion Pumps
4.5.3.4. Nebulizers
4.5.3.5. Oxygen Equipment
4.5.3.6. Continuous Positive Airway Pressure (CPAP)
4.5.3.7. Suction Pumps
4.5.3.8. Traction Equipment
4.5.3.9. Others
4.5.3.9.1. Insulin Pumps
4.5.3.9.2. Ostomy Bags & Accessories
4.5.3.9.3. Wound Care Products
4.5.3.9.4. Cardiology Devices
4.5.3.9.5. Vital Signs Monitor
4.5.3.9.6. Respiratory Supplies
4.5.3.9.7. Urinary Supplies
4.5.3.9.8. Diabetic Supplies
4.5.3.9.9. Incontinence Products
4.5.3.9.10. Orthopedic Braces & Support
4.5.3.9.11. Muscle Stimulators
4.5.3.9.12. Others
Chapter 5. U.S. Durable Medical Equipment Market: End-use Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. End-use segment market analysis
5.1.1.1. Hospitals
5.1.1.2. Specialty Clinics
5.1.1.3. Ambulatory Surgical Centers
5.1.1.4. Diagnostic Centers
5.1.1.5. Home Healthcare
5.1.1.6. Others
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Innovators
6.3. Vendor Landscape
6.3.1. List Of Key Distributors and Channel Partners
6.3.2. Key Customers
6.3.3. Key Company Market Share Analysis, 2021
6.3.4. Invacare Corporation
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Sunrise Medical
5.3.5.1. Company overview
5.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. ArjoHuntleigh
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. Hill-Rom
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. Stryker
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. Medline Industries, Inc.
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. Medical Device Depot, Inc.
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
6.3.11. GF Health Products Inc.
6.3.11.1. Company overview
6.3.11.2. Financial performance
6.3.11.3. Product benchmarking
6.3.11.4. Strategic initiatives
6.3.12. Carex Health Brands
6.3.12.1. Company overview
6.3.12.2. Financial performance
6.3.12.3. Product benchmarking
6.3.12.4. Strategic initiatives
6.3.13. Baxter International, Inc.
6.3.13.1. Company overview
6.3.13.2. Financial performance
6.3.13.3. Product benchmarking
6.3.13.4. Strategic initiatives
6.3.14. Becton, Dickinson, and Company
6.3.14.1. Company overview
6.3.14.2. Financial performance
6.3.14.3. Product benchmarking
6.3.14.4. Strategic initiatives
6.3.15. Joerns Healthcare LLC
6.3.15.1. Company overview
6.3.15.2. Financial performance
6.3.15.3. Product benchmarking
6.3.15.4. Strategic initiatives